|
Lysates
HeLa Lysate
Background
HeLa lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The HeLa lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.
Cell Line
HeLa-S3 (Human Cervix Epithelioid Carcinoma)
Tested Application
WB
Buffer
HeLa lysate is supplied in SDS sample buffer containing 5% β-mercaptoethanol.
Storage
Lysate is supplied at a concentration of 2 mg/ml. Store at 2-8˚C for continuous use. For extended storage, freeze working aliquots at -70˚C. Repeated freezing and thawing is not recommended. Under proper storage conditions the shelf life is half a year from the date of receipt.
Species Reactivity
n/a
Species
Human
Short Description
cervix epithelioid carcinoma
Growth Media
Jokliks-MEM and 5% NCS (newborn calf serum)
This product belongs to the following categories:
Related Products
Datasheet 0802-W
|
|
